Information for module PHARG031
This module is available for: The current academic year
If you're a member of UCL you can add this module to your personalised course list
This information is for guidance only. If you are a UCL undergraduate interested in studying one of these courses, you must seek permission from both the providing department and your 'home' department. Appearance in this database is not a guarantee that a course is running in any particular academic year.
|Module code:||PHARG031(Add to my personalised list)|
|Division:||Division of Biosciences|
|Module organiser:||Dr Dean Willis|
|Available for students in Year(s):||1,|
|Module prerequisites:||2nd Year Pharmacology (PHAR2002 [B15], Preclinical. Students who have taken other courses should consult the course organiser|
|Module outline:||As our knowledge of human disease increases it is becoming evident that inflammation plays a significant part in many pathologies. The diseases in which inflammation has a major role, not only includes the classical inflammatory diseases, such as asthma, arthritis, allergies and the auto-immune pathologies, but also atherosclerosis, ischemic-reperfusion injury, sepsis/multiply organ failure and COPD. Inflammation is also an important component of metabolic diseases, with evidence suggesting a link between diabetes obesity and inflammation, is an important of tumor genesis and is the underlying mechanism by which transplants are rejected. This course provides in-depth coverage of the core mechanism by which inflammation is initiated and maintained and discusses the state of the current and future research trends in its treatment.|
|Module aims:||The aim of immunopharmacology is provide up-to-date information on the pharmacology of the mediators and cells which drive inflammation, how they interact to provide a robust response, and how dysfunctions in these pathways lead to pathology. The course will also describe currently used anti-inflammatory drugs and investigate future trends in this area of pharmacological research.|
|Module objectives:||i) To know which cells and mediators are key in the development of an inflammatory response ii) To understand the criteria used to assess whether or not endogenous substances may be described as mediator of inflammation. iii) To be able to explain the mechanism of action of drugs which are used to control the inflammatory process. iv) To appreciate current trends in inflammatory mediator and anti-inflammatory drug research ï¿½ To understand in particular the pathology of asthma and rheumatoid arthritis and the therapeutic approaches towards these diseases ï¿½ To develop your skills in literature searches, literature/research evaluation, study design and presentation of a research proposal|
|Key skills provided by module:||In addition to providing an update overview of immunopharmacology, the course aims to provide the skills which are required when formulating, justifying and presenting a project. These skills not only have relevance to the preparation of research proposals/grants but also to general project management proposals and in formulating and preparation of business plans.|
|Module assessment:||One essay (3,000 words) 25.00%.|
Unseen two-hour written examination 50.00%.
Invigilated examination question 25.00%.
|Taking this module as an option?:|
|Link to virtual learning environment(registered students only)|
|Last updated:||2012-07-16 14:52:33 by|